Michael Howland

Title: Michael Howland: Innovator in Cholangiocarcinoma Treatment

Introduction

Michael Howland is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medicine, particularly in the treatment of cholangiocarcinoma, a rare and aggressive form of cancer. His innovative approach has the potential to improve patient outcomes and advance cancer treatment methodologies.

Latest Patents

Michael Howland holds a patent for "Methods of treating cholangiocarcinoma." This patent outlines methods for treating advanced or metastatic cholangiocarcinoma in patients by administering infigratinib or a pharmaceutically acceptable salt thereof. This treatment is particularly relevant for patients who have experienced progression of the disease after previous therapies. He has 1 patent to his name.

Career Highlights

Michael Howland is currently associated with QED Therapeutics, Inc., where he continues to work on innovative solutions for cancer treatment. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Riccardo Panicucci and Michael Monteith. Their collective expertise enhances the research environment at QED Therapeutics, Inc., fostering innovation and development in cancer therapies.

Conclusion

Michael Howland's work in the treatment of cholangiocarcinoma exemplifies the impact of innovation in medicine. His contributions are paving the way for new therapeutic options for patients facing this challenging disease.